Monoclonal antibody | |
---|---|
Type | ? |
Target | CD70 |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
KEGG | |
Chemical and physical data | |
Formula | C6476H10006N1726O2028S50 |
Molar mass | 146.1 kg/mol |
Vorsetuzumab is a monoclonal antibody developed by Seattle Genetics, designed for the treatment of cancer.
Chemical names are: